Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,576 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT04649073

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tokai University Hospital Isehara-shi, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • National Hospital Organization Okayama Medical Center Okayama, Japan
  • Sapporo Medical University Hospital Sapporo, Japan
View Trial Details
Active, Not Recruiting

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

NCT01761968

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Charite Research Organization GmbH Berlin, Germany
  • Universitaetsklinikum Freiburg, Innere Medizin I - Haematologie und Onkologie Freiburg im Breisgau, Germany
  • Azienda Ospedaliero-Universitaria Policlinico Consorziale, Bari Bari, BA, Italy
  • Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico di Bari Bari, BA, Italy
View all 15 locations
View Trial Details
Active, Not Recruiting

A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

NCT06185335

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Russia
  • State budgetary healthcare institution Leningrad Regional Clinical Hospital Gatchina, Russia
  • Kuzbass Clinical Hospital named after S.V. Belyaev Kemerovo, Russia
  • Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency" Kirov, Russia
View all 17 locations
View Trial Details
Active, Not Recruiting

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

NCT03376672

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Central Finland Central Hospital Jyväskylä, Finland
  • Kainuu Central Hospital Kajaani, Finland
  • Kymenlaakso Central Hospital Kotka, Finland
View all 26 locations
View Trial Details
Active, Not Recruiting

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

NCT04392037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • NWZ Alkmaar, Netherlands
  • Amsterdam UMC, location AMC Amsterdam, Netherlands
  • Amsterdam UMC, location VUmc Amsterdam, Netherlands
  • Rijnstate Arnhem, Netherlands
View Trial Details

Related conditions